Nice find triage. I’m posting the link below because the pay wall didn’t come up through this link. https://www.google.com.au/amp/s/www.nytimes.com/2021/01/11/health/colonoscopy-health-home-testing.amp.html In my opinion, ColoSTAT is a game changer when you think about it’s unique advantages over FIT or colonoscopy, and the levels of accuracy it’s achieving in trials look highly promising that it’s going to be a market leader. Massive market here and globally. Very exciting stock to be holding. Thanks for the article.
RHY Price at posting:
$1.20 Sentiment: Buy Disclosure: Held
